Submitted by Anonymous (not verified) on 21 October 2026 - 12:28
Human medicines European public assessment report (EPAR): Anzupgo, delgocitinib, Date of authorisation: 19/09/2024, Revision: 5, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Anzupgo, delgocitinib, Date of authorisation: 19/09/2024, Revision: 5, Status: Authorised